- Citations, last 5 years
- 43
- Works, last 5 years
- 4
- h-index
- 2
- Scientists listed
- 0
- Grants since 2016
- 11
Grants received
2024–2026 · grant · HORIZON - HORIZON-EIC-ACC-BF
Breakthrough dual-action OTC tablet for treatment and prevention of both bacterial and fungal vaginitis
Gedea Biotech (Sweden) · funded by HORIZON EUROPE European Innovation Council
2023 · grant · Project grant
Gedea EIC accelerator preparation project
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA
2023–2024 · grant · Project grant
A new, safe and resistance-free treatment of vaginal fungal and bacterial infections
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA
2020–2022 · research · H2020 - IA
A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs
Gedea Biotech (Sweden) · funded by European Commission
2019–2022 · grant · Project grant
A new, safe and resistance-free treatment of vaginal fungal and bacterial infections
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA
2019 · grant · JPI AMR
Develop a Partnerships Strategy to ensure key stakeholders, including industry and policy makers, and other networks are engaged and coordinate the alignment of other funded Networks
Annette Säfholm · Gedea Biotech (Sweden) · funded by Agence Nationale de la Recherche
2018–2019 · commercial · H2020 - SME-1
NEFERTITI: A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs
Gedea Biotech (Sweden) · funded by European Commission
2018–2019 · grant · Project grant
A novel, safe and resistance-free treatment
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA
2017 · grant · Project grant
A novel, safe and resistance-free treatment of vaginal candida infections
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA
2017–2018 · grant · Project grant
A novel, safe and resistance-free treatment of vaginal candida infections
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA
2017 · grant · Project grant
Travel Grant Great Britan
Annette Säfholm · Gedea Biotech (Sweden) · funded by VINNOVA